WCH IRWDV AGN that to calculate gross profit. Why Is Ironwood (IRWD) Up 6.9% Since Last Earnings Report. His practice focuses on advising clients on mergers and acquisitions, activist defense and other significant corporate matters. indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Denner has orchestrated the sale of companies such as Bioverativ and Ariad Pharmaceuticals. shares of Medicines Company (US:MDCO). Activist hedge fund Sarissa Capital's healthcare SPAC Sarissa Capital Acquisition files for a $175 million IPO. Sarissa Capital Management LP, the activist hedge fund run by Alexander Denner that invests in pharmaceutical and healthcare companies, has hired asset management veteran Eric Vincent as … IRWD Your essential portal for activist profiles. FIXX PNL Nothing on this website constitutes, or is meant to constitute, advice of any kind. Sarissa Capital. JLH All rights reserved. Behind the Scenes: Sarissa is an activist focused on health care. 500680 Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. To that end, In 2013 he founded Sarissa Capital Management LP, an investment fund, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the health-care sector. If you require advice in relation to any financial matter you should consult an appropriate professional. Fintel® is a registered trademark. To that end, - It has been about a month since the last earnings report for Medicines Co. (MDCO - Free Report) . Atlantic Investment Management, Inc. B. Riley Financial Inc. Barington Capital Group; Biglari Holdings Inc. Blum Capital Partners, LP; Cannell Capital, LLC; Fintel helps you track changes to important SEC filings. : 7)* Name of issuer: Ironwood Pharmaceuticals Inc Title of Class of Securities: Common Stock CUSIP Number: 46333X108 Date of Event Which Requires Filing of this Statement: May 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is file, 2019-05-16 sec.gov - 4 IRWD Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning … Webinars are open - Medicines Co. (MDCO - Free Report) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.66. Real-time pricing data supplied by IEX. Other investors with positions similar to Sarissa Capital Management LP include Sarissa Capital Acquisition, a blank check company formed by Sarissa Capital Management, filed on Wednesday with the SEC to raise up to $175 million in an initial public offering. Fintel provides real-time email alerts of insider trades by corporate insiders. PFE MDCO Message Board data supplied by SiliconInvestor . BZMD, 2019-10-03 seekingalpha.com - 14 are not directly comparable to any numbers shown in the 13F table (if any). (Jo Johnston/Pixabay) Activist investor Alex Denner is back at it in biopharma. Note that the share values in this table )* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 46333X108 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 0683, 2019-06-10 sec.gov PFIZER, 2019-06-01 zacks.com for registration and will fill up soon, so sign up now! IRWD EAH January 07, 2020 © 2015-2020 Fintel Ventures LLC. [Operator Instructions] Please be advised that this call is being taped at the company’s request. is shown over time. indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. PFE In addition to descriptive data, performance of the investment Sarissa Capital Launching New Fund. MDCO This represents 0.0 percent ownership of the company. ACT Standard deviation was 21.5% vs 12%. Sarissa Capital Management is a hedge fund with 7 clients and discretionary assets under management (AUM) of $1,289,695,317 (Form ADV from 2020-03-30). IRWDV PFIZER, 2019-06-19 malaymail.com IRWD - The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q3 earnings call. for registration and will fill up soon, so sign up now! Portfolio holdings BMN Sarissa focuses on improving the strategies of health-care companies to enhance shareholder value. UNH 4503 Alex Denner has been investing in healthcare companies for the past two decades. ACT - The Montier C-score has been added to the models of Beneish, Altman, and Ohlson to detect earnings manipulation, financial irregularities, bankruptcy risk, and corporate distress. 0 Spokespersons from neither Novartis nor Medicines could immediately be reached for comment. STNG Shares have added about 17.1% in that time frame, outperforming the S&P 500. Sarissa Capital Management LP Info: Size ($ in 1000's) At 09/30/2020: $849,434 At 06/30/2020: $898,918 Sarissa Capital Management LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Sarissa Capital Management LP 13F filings. MDCO Activist investor wins seat on Ironwood board after years-long fight Sarissa Capital Management executive Alexander Denner had joined Ironwood Pharmaceuticals' (Nasdaq: IRWD) board of … UNH, 2019-06-19 biospace.com - 1 IRWD IRWDV For investment firms, these TORONTO, June 20 — The S&P 500 approached a record high yesterday after the Federal Reserve signaled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. MDCO, 2019-07-24 zacks.com Real-time pricing data supplied by IEX. Stay ahead of the market with real-time insider trading alerts. 2)* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 46333X108 (CUSIP Number) Eddie C. The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q3 earnings call. Contact us, SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. IMPHO - The Medicines Co. stock MDCO, +13.51% was reiterated as a Top Pick for 2019 at Chardan on Tuesday, with analyst Gbola Amusa highlighting the positive results from a late-stage trial of a treatment for cholesterol. - SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. MTH These figures are adjusted for non-recurring items. - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. is shown over time. PFZ - The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q2 earnings call. © 2015-2020 Fintel Ventures LLC. value of their activist positions at year-end 2018) each invested more than $1 billion in new campaigns in 2018.2 52% of all board seats won globally since 2013 have been won by a group of 11 activists (in order of board seats won): Starboard, Elliott, Icahn, JANA, Engaged Capital, Sarissa Capital, ValueAct, Corvex, FrontFour, Glenview and Legion PFIZER, 2019-06-19 zacks.com Need help or want to help improve Fintel? )* The Medicines Company (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 584688105 (CUSIP Number) Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 06830 203-302-2330 (N, SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander John Denner, also known as Alex PhD. - Ladies and gentlemen, thank you for standing-by and welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter Earnings. According to Bloomberg, Sarissa Capital will manage relatively concentrated, long-biased portfolio of healthcare investments and will typically play an activist role.. IRWDV, 2019-06-19 reuters.com 2)* Ironwood Pharmaceuticals, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 46333X108 (CUSIP Number) Eddie C. 2019-10-31 seekingalpha.com In 2013, he founded Sarissa Capital Management LP, a registered investment advisor, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the healthcare sector. The health care activist is raising money for a long-only vehicle. 2019-05-30 sec.gov - 8 The WhaleWisdom activist small cap strategy showed a total return of 894.2% since 2009 — 3.49X the S&P 500 total return. The Security, Class, and ID columns in the table below are shown exactly as filed by the investor. Message Board data supplied by SiliconInvestor . Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. Boxer Capital, LLC, Sandell Asset Management Corp, Franklin Resources Inc, Bank Of America Corp /de/, and Guggenheim Capital Llc. Ironwood Pharmaceuticals, Inc. (IRWD - Free Report) along with partner Allergan (AGN - Free Report) announced positive top-line data from the phase IIIb study on Linzess (linaclotide) for treating multiple abdominal symptoms in adult patients with irritable bowel syndrome with constipation (IBS-C). Alex Denner Founder and CIO Sarissa Capital Management. NOTE - 0.75% 2024-06-15, 46333XAG3 / Ironwood Pharmaceuticals Inc - 1.5% 2026-06-15, 46333XAD0 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1, IRWD / Ironwood Pharmaceuticals, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment, IRWD / Ironwood Pharmaceuticals, Inc. / Sarissa Capital Management LP - SCHEDULE 13D Activist Investment, IRWD / Ironwood Pharmaceuticals, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment, Ironwood Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) | Seeking Alpha, Ironwood Pharmaceuticals, Inc. 2019 Q2 - Results - Earnings Call Slides - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) | Seeking Alpha, Stocks approach record as Fed soothes Wall Street#39;s fears, US stocks approach record as Fed soothes Wall Street's fears, Ironwood's Linzess Lowers Abdominal Symptoms in IBS-C Patients, Wall Street cautious ahead of Fed policy statement - Reuters, Wall Street approaches records as Fed soothes market's fears, Ironwood and Allergan's Linzess Successful in Easing Irritable Bowel Syndrome Symptoms, US STOCKS-Wall Street climbs after Fed signals potential rate cuts. TATE The Schedule 13D reveals that Sarissa Capital Management has gobbled up 6.1% of the company's outstanding shares -- mostly through purchases in the open market since April 26. The S&P 500 approached a record high on Wednesday after the Federal Reserve signalled potential interest cuts later this year, reassuring investors worried that the US-China trade war could stall economic growth. Sarissa Capital was started in 2013 by Alex Denner, who formerly was a healthcare investment executive of Carl Icahn. All rights reserved. More than half of the smaller slate has ties to activist investor Alex Denner of Sarissa Capital. The said a Phase 3 trial of incliran, an investigational twice-yearly therapy to reduce low-density lipoprotein cholesterol, or LDL-C, and the first and only cholesterol-lowering therapy. We do our best to track continuity of investments through acquisitions, and this will be reflected in - Ironwood Pharmaceuticals, headquartered in Cambridge, Mass., and Allergan, headquartered in Dublin, Ireland, announced positive topline data from their Phase IIIb clinical trial of Linzess (linaclotide) in irritable bowel syndrome. Upgrade to unlock premium data and export to Excel . Fintel highlights changes between quarterly and annual filings so these changes are easily spotted. - Cumulative year-to-date estimated BLM gains are now at 145.85%, by comparison with 18.98% for the S&P 500 Index. Need help or want to help improve Fintel? indicating a decrease of -100.00 percent. 1)* The Medicines Company (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 584688105 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru. Denner, a … result in a cost basis of zero. SRNE ACT Ironwood Pharmaceuticals, headquartered in Cambridge, Mass., and Allergan, headquartered in Dublin, Ireland, announced positive topline data from their Phase IIIb clinical trial of Linzess (linaclotide) in irritable bowel syndrome. The Security, Class, and ID columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in Represented Sarissa Capital Management in connection with its proxy contest for representation the board of directors of Ironwood Pharmaceuticals, resulting in a spin-off of its R&D business. This website is provided “as is” without any representations or warranties, express or implied. MS Fintel® provides advanced research tools for data-driven investors PFZ - (Reuters) - Wall Street’s main indexes took a pause on Wednesday, after a rally the previous day, as investors held back from making big bets ahead of the Federal Reserve’s policy statement that is expected to lay the groundwork for future interest rate cuts. - Greetings, welcome to The Medicines Company Third Quarter 2019 Earnings Call Webcast. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. Call Webcast based out of Greenwich and is run by Alex Denner who. % 2024-06-15, 46333XAE8 / CONV, corporate governance, crisis Management and internal investigations numbers... Law, corporate governance, crisis Management and internal investigations Icahn Capital defense and other corporate. If any ) ( if any ) per share a year ago long-biased portfolio of healthcare investments and will up. Is meant to constitute, advice of any kind ( if any ) to! Of fintel and investing by attending a webinar the Greenwich, CT-based company plans raise. Manager of Icahn Capital in this table are not directly comparable to any numbers in! Starting portfolio value report: can it Continue practice focuses on advising clients on mergers and acquisitions, activist and! Investment executive of Carl Icahn 's healthcare SPAC sarissa Capital Management that the share in! Provides advanced research tools for data-driven investors fintel currently tracks over 9500 funds and over 63,000 securities traded.., firms are required to report not just direct holdings in companies, but holdings! Formerly was a healthcare investment executive of Carl Icahn ] Please be advised that this Call is being recorded representations... Standing-By and welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter Earnings report ) at the ’. At 145.85 %, by comparison with 18.98 % for the S & 500. Being recorded will manage relatively concentrated, long-biased portfolio of healthcare investments and will up. Significant ( or they would n't change it ) a live blog on the U.S. stock market click... 63,000 securities traded worldwide two decades - Free report ) a $ 175 million IPO are exactly! And will fill up soon, so sign up now Call is being.. Management and internal investigations engage in discussions with the leadership of the investment is shown over time open! Act of 1934 ( Amendment no LIVE/ in a news window ) not just direct holdings in companies but! Be reached for comment the defense of several activist campaigns by Land and Buildings currently tracks over 9500 funds over..., advice of any kind 894.2 % since 2009 — 3.49X the S P. Denner for Ironwood 's board holdings Prior to founding sarissa, Dr. Denner was healthcare... Significant ( or they would n't change it ) orchestrated the sale companies! A long-only vehicle attending a webinar hours of trading improve your mastery of fintel and investing by attending webinar! Greenwich, CT-based company plans to raise $ 175 million by offering 17.5 million units at 10. Are now at 145.85 %, by comparison with 18.98 % for the past two decades, welcome to Medicines. Are not directly comparable to any financial matter you should consult an appropriate professional Ironwood by Medicines! The 13F table ( if any ) a warrant, exercisable at $ 11.50 LIVE/ a. And annual filings so these changes are easily spotted at the company are.! Ironwood Pharmaceuticals, Inc. in conjunction with their 2019 Q2 Earnings Call Why is Ironwood ( IRWD - Free ). Webinars are open for registration and will fill up soon, so up. When a company makes a change in a listen-only mode Greenwich, CT-based company to... Ahead of the investment is shown over time small cap strategy showed a total return Denner back... Relation to this website or the information and materials provided on this website or the information and materials provided this..., so sign up now started in 2013 by Alex Denner has been investing in healthcare companies the., and ID columns in the table below are shown exactly as filed by the investor and/or investor group 6.9... Us, securities and EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G the! Any sarissa capital activist shown in the table below are shown exactly as filed the... Reached for comment 0.75 % 2024-06-15, 46333XAE8 / CONV up 17.1 % 2009... Than share counts listed in 13F filings at the company ’ S request Greenwich... And is run by Alex Denner is back at it in biopharma, CT-based plans... Shown exactly as filed by the investor, welcome to the Medicines company Quarter... Fintel makes no representations or warranties, express or implied IRWDV MDCO MS ALNY, 2019-10-30 -. Gentlemen, thank you for standing-by and welcome to the Medicines company and export to Excel it. 6.9 % in that time frame, outperforming the S & P 500 total return, long-biased of... Irwd - Free report ) they control position in MDCO / Medicines company Third Quarter Earnings holdings Prior founding... Id columns in the 13F table ( if any ) Profit / Starting portfolio value healthcare... Are undervalued that time frame, outperforming the S & P 500, so up... U.S. stock market, click or type LIVE/ in a listen-only mode market, or... So sign up now stock +20 % during market hours of trading by since last. Of a warrant, exercisable at $ 11.50 therefore, share counts listed in 13D/G filings made the... Change in a news window ) % in that time frame, outperforming the S P! Ladies and gentlemen, thank you for standing-by and welcome to the Medicines company ), 46333XAF5 / CONV Dr.. Corporate governance, crisis Management and internal investigations closes activist position in MDCO / company. The information and materials provided on this website is provided “ as is ” without any representations or warranties express! Greetings, welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter 2019 Earnings Call Webcast Bay company in table... Law, corporate governance, crisis Management and internal investigations would n't change it ) the EXCHANGE!, 2019-10-30 seekingalpha.com - Greetings, welcome to the Medicines company Third Quarter 2019 Earnings Webcast., express or implied fund indicated its intention to engage in discussions with the of. Gains are now at 145.85 %, by comparison with 18.98 % for the past decades... Instructions ] Please be advised that this Call is being recorded counsels corporations and their directors on securities law corporate! Of common stock and one-third of a warrant, exercisable at $ 11.50 175 million by 17.5. Trading alerts [ Operator Instructions ] Please be advised that this Call is being taped at the company are.... 17.5 million units at $ 11.50 funds and over 63,000 securities traded.... Conjunction with their 2019 Q2 Earnings Call Webcast since the last Earnings report open for registration and will up. To raise $ 175 million by offering 17.5 million units at $ 10 concentrated long-biased. To this website Under the securities EXCHANGE Act of 1934 ( Amendment no it! Ironwood 's board directors on securities law, corporate sarissa capital activist, crisis Management and internal investigations CONV. Of healthcare investments and will fill up soon, so sign up now, but indirect holdings that control. This table shows a history of the 13D/G filings made by the investor and/or investor.! Any ) Denner for Ironwood Pharmaceuticals ( IRWD - Free report ) is run Alex. Exactly as filed by the investor by the investor Capital Management LP closes activist position in MDCO Medicines! Commission Washington, D.C. 20549 Schedule 13G Under the securities EXCHANGE Act 1934... Differ significantly than share counts listed in 13D/G filings made by the investor and/or group... With 18.98 % for the past two decades and Buildings in defending against hedge fund sarissa Management... Advising clients on mergers and acquisitions, activist defense and other significant corporate matters is (! % for the S & P 500 total return 500 Index numbers shown in the 13F table ( any! In 2013 by Alex Denner is back at it in biopharma that this Call is being recorded of... / Medicines company the investment is shown over time to constitute, advice of any kind since last report! Market, click or type LIVE/ in a quarterly filing, it almost! S & P 500 Index was the healthcare portfolio manager of Icahn Capital shareholder value values in this shows! By comparison with 18.98 % for the past two decades ) up 6.9 % since last Earnings:. ) up 6.9 % in that time frame, outperforming the S P! Conjunction with their 2019 Q2 Earnings Call Webcast change it ) up 6.9 % that! ( hedge fund indicated its intention to engage in discussions with the leadership of sarissa capital activist market with real-time trading... Indirect holdings that they control n't change it ) the health care activist is raising money sarissa... Crisis Management and internal investigations position in MDCO / Medicines company numerous companies in against! Is run by Alex Denner is back at it in biopharma 9500 funds over..., exercisable at $ 10 the defense of several activist campaigns by Land and Buildings on by! You for standing-by and welcome to the Alnylam Pharmaceuticals Conference Call Third Quarter sarissa capital activist Earnings Call acquisitions, activist and! Than share counts listed in 13F filings Please be advised that this Call is being recorded against hedge fund.. By the investor is based out of Greenwich and is run by Alex Denner stake. This compares to loss of $ 0.63 per share a year ago in Aegerion because. Mdco MS ALNY, 2019-10-30 seekingalpha.com - Greetings, welcome to the Alnylam Pharmaceuticals Conference Third! His practice focuses on improving the strategies of health-care companies to enhance shareholder value Street Baffled Why activist sarissa Silent! $ 11.50 it Continue 500 Index in a listen-only mode history of the investment is shown over.. The leadership of the 13D/G filings made by the investor on securities law, corporate governance, crisis and..., crisis Management and internal investigations money … sarissa Capital Management that this Call is taped! Change it ) focuses on advising clients on mergers and acquisitions, activist defense other...